Genetic factors contribute to bleeding after cardiac surgery
I J Welsby1, M V Podgoreanu, B Phillips-Bute
1Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. welsb001@mc.duke.edu
Journal of Thrombosis and Haemostasis : JTH
|May 17, 2005
Summary
Genetic factors significantly impact bleeding risk in cardiac surgery patients. Identifying specific gene variations can double the ability to predict postoperative bleeding, improving patient risk assessment.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Coagulation Science
Background:
- Postoperative bleeding is a significant complication in cardiac surgery.
- Patient variability in bleeding is not fully explained by current clinical markers.
Purpose of the Study:
- To investigate the association between genetic polymorphisms in coagulation proteins and platelet glycoproteins with postoperative bleeding.
- To determine if genetic factors improve the prediction of bleeding after cardiac surgery.
Main Methods:
- Studied 780 patients undergoing aortocoronary bypass surgery.
- Analyzed DNA for genetic polymorphisms using MALDI-TOF mass spectroscopy or PCR.
- Utilized multivariable regression to model genetic and clinical predictors of bleeding.
Main Results:
- Seven genetic polymorphisms (GPIaIIa, GPIb alpha, tissue factor, prothrombin, TFPI, ACE) were significantly associated with bleeding (P < 0.01).
- Incorporating genetic predictors into clinical models doubled the ability to predict bleeding (P < 0.01).
Conclusions:
- Identified seven key genetic polymorphisms linked to cardiac surgery bleeding.
- Genetic factors independently explain significant bleeding variation, comparable to clinical factors.
- Combining genetic and clinical data enhances bleeding risk prediction, suggesting genotype consideration for risk stratification.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...